HAI
IONS icon

Hennessy Advisors Inc’s Ionis Pharmaceuticals IONS Stock Holding History

Hennessy Advisors Inc’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,650
Closed -$337K – 299
2018
Q1 		$337K Buy
+7,650
New +$389K 0.01% 335

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Hennessy Advisors Inc's IONS Position: Q2 2018 in Review

Hennessy Advisors Inc sold out of Ionis Pharmaceuticals (IONS) in Q2 2018, closing a stake of 7,650 shares — an estimated $337K sold.

Hennessy Advisors Inc first reported a position in IONS in Q1 2018 and held it in 1 quarter. The position peaked at $337K in Q1 2018. 307 funds tracked by Wall St. Rank hold IONS as of Q2 2018.

  • Hennessy Advisors Inc reported no remaining Ionis Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Hennessy Advisors Inc sold 7,650 Ionis Pharmaceuticals shares in Q2 2018, an estimated $337K.
  • Hennessy Advisors Inc first reported a position in Ionis Pharmaceuticals in Q1 2018 and held it in 1 quarter.
  • Hennessy Advisors Inc's Ionis Pharmaceuticals position peaked at $337K in Q1 2018.
  • 307 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2018.

Based on Hennessy Advisors Inc's 13F filing for Q2 2018, filed 20 Jul 2018.